Is Chlormethine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 1 valid registration of Chlormethine, including Ledaga 160 micrograms/g gel (160 µg/g, Gel, SAR 6183.15).

Is Chlormethine authorised in the European Union?

EMA lists 1 centrally authorised medicine containing Chlormethine: Ledaga.

Active substance

Chlormethine

SFDA 1
EMA 1
Health Canada 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
Ledaga 160 micrograms/g gel	160 µg/g	Gel · Topical	1 Tube	SAR 6183.15	NCE · Prescription	Recordati Rare Diseases	Valid

EMA European Union — centrally authorised medicines

Ledaga Helsinn Birex Pharmaceuticals Ltd. · Authorised · authorised 3 Mar 2017 · ATC L01AA05

Therapeutic indication (EMA)

Ledaga is indicated for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma (MF-type CTCL) in adult patients.

Canada Canada — marketed products (Health Canada)

Brand	DIN	Strength	Form · route	Company
LEDAGA	02516764	160 MCG / G	GEL · TOPICAL	RECORDATI RARE DISEASES CANADA INC

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.